KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) EBT Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 535.00
Dec 31, 2025 10,618.00
Sep 30, 2025 406.00
Jun 30, 2025 -161.00
Mar 31, 2025 2,934.00
Dec 31, 2024 304.00
Sep 30, 2024 -836.00
Jun 30, 2024 -1,777.00
Mar 31, 2024 -13,049.00
Dec 31, 2023 -1,061.00
Sep 30, 2023 -1,859.00
Jun 30, 2023 750.00
Mar 31, 2023 -982.00
Dec 31, 2022 349.00
Sep 30, 2022 -282.00
Jun 30, 2022 -870.00
Mar 31, 2022 -2,518.00
Dec 31, 2021 -521.00
Sep 30, 2021 -1,312.00
Jun 30, 2021 -1,989.00
Mar 31, 2021 -1,484.00
Dec 31, 2020 -8,486.00
Sep 30, 2020 -284.00
Jun 30, 2020 1,481.00
Mar 31, 2020 -3,865.00
Dec 31, 2019 -21.00
Sep 30, 2019 -325.00
Jun 30, 2019 1,679.00
Mar 31, 2019 758.00
Dec 31, 2018 563.00
Sep 30, 2018 1,795.00
Jun 30, 2018 -403.00
Mar 31, 2018 1,666.00
Dec 31, 2017 57.00
Sep 30, 2017 5,622.00
Jun 30, 2017 134.00
Mar 31, 2017 106.00
Dec 31, 2016 -851.00
Sep 30, 2016 -256.00
Jun 30, 2016 21.00
Mar 31, 2016 243.00
Dec 31, 2015 658.00
Sep 30, 2015 -938.00
Jun 30, 2015 -3,214.00
Mar 31, 2015 563.00
Dec 31, 2014 -2,764.00
Sep 30, 2014 -698.00
Jun 30, 2014 -2,111.00
Mar 31, 2014 -180.00